scispace - formally typeset
E

Eva Latulippe

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  8
Citations -  3286

Eva Latulippe is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 5, co-authored 5 publications receiving 3204 citations.

Papers
More filters
Journal ArticleDOI

Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance

TL;DR: A genome-wide expression analysis of human prostate cancer during androgen ablation therapy to identify genes regulated by androgen and genes differentially expressed after the development of resistance suggested that resistant tumors have increased sensitivity to and endogenous synthesis of androgenic hormones.
Journal Article

Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

TL;DR: A strong correlation between high proliferation rates in metastatic cancers and overexpression of genes that participate in cell cycle regulation, DNA replication, and DNA repair and other functional categories of differentially expressed genes included transcriptional regulation, signaling, signal transduction, cell structure, and motility.
Journal ArticleDOI

Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice

TL;DR: The hypothesis of PTC acting as a tumor suppressor gene in bladder cancer is supported by data submitted Ptc+/− heterozygous mutant mice and their wild-type littermates to chemical carcinogenesis by adding N-butyl-N-(4-hydroxybutyl) nitrosamine to their drinking water.
Journal ArticleDOI

Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.

TL;DR: In this paper, the expression of COX-2 was evaluated immunohistochemically with a monoclonal anti-COX-1 antibody and showed an increased disease-specific survival (P= 0.0063), as well as longer recurrence-free survival and a tendency was also observed in a subgroup with positive nodes treated with adjuvant chemotherapy.